Trial Profile
Effect of dabigatran etexilate in patients with non-valvular atrial fibrillation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 May 2015
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Embolism and thrombosis
- Focus Therapeutic Use
- 26 May 2015 New trial record